Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-001840
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27668
2 filename2.txt TEXT-EXTRACT 1498
  Complete submission text file 0000000000-21-001840.txt   40326
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances